Related Experiment Video
Updated: May 18, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
Predictions for cholesterol interaction sites on the A2A adenosine receptor
1Department of Physics and Astronomy, University of Delaware, Newark, Delaware 19716, USA.
Molecular dynamics simulations reveal cholesterol binding sites on the adenosine A(2A) receptor. These interactions, crucial for receptor function, were identified in both extracellular and intracellular regions, with one site validated by recent structural data.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The adenosine A(2A) receptor (A(2A)R) is a G protein-coupled receptor involved in various physiological processes.
- Cholesterol is known to modulate the function of membrane proteins, including GPCRs.
- Understanding ligand-receptor-cholesterol interactions is key to drug discovery.
Purpose of the Study:
- To investigate the specific binding sites of cholesterol on the adenosine A(2A) receptor.
- To elucidate the role of cholesterol in modulating A(2A)R function and ligand binding.
Main Methods:
- Extensive molecular dynamics (MD) simulations of the adenosine-bound A(2A) receptor were performed.
- Total simulation time reached 1.4 microseconds.
- Analysis focused on identifying stable interaction sites between cholesterol and the receptor.
Main Results:
- Clear evidence for specific cholesterol binding sites on the A(2A) receptor was identified.
- Three primary binding sites were detected: two in the extracellular leaflet (interacting with helices VII/I and II/III) and one in the intracellular leaflet (interacting with helices III/IV).
- One predicted binding site was experimentally validated by a recently published high-resolution crystal structure of A(2A)R complexed with an antagonist.
Conclusions:
- Cholesterol directly interacts with the adenosine A(2A) receptor at specific membrane-associated sites.
- These interactions likely influence receptor conformation and function.
- The findings provide a structural basis for understanding cholesterol's role in A(2A)R pharmacology.
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

